Retour

Choisissez votre région

Corporate

Demandez un entretien de conseil sur les cellules souches

En savoir plus

Liste des patients
traités

Liste des utilisations des cellules souches approuvées par les laboratoires du groupe Famicord:

Image
Liste des utilisations des cellules souches approuvées par les laboratoires du groupe Famicord:
Nr. Source Type de source Diagnostic Domaine médical Année d’application Thérapie Pays Âge du bénéficiaire
6501 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 27
6502 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 70
6503 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 39
6504 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 71
6505 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 32
6506 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 59
6507 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 59
6508 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 63
6509 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 67
6510 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 65
6511 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 66
6512 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 48
6513 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 60
6514 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 57
6515 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 46
6516 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 49
6517 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 4
6518 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 67
6519 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 69
6520 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 63
6521 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 8
6522 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 58
6523 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 61
6524 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Poland 67
6525 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Germany 61
6526 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Germany 65
6527 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Germany 57
6528 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2018 Standard Therapy Germany 27
6529 Apheresis Allogeneic Myelodysplastic Syndrome – Raeb Hematology 2018 Standard Therapy Poland 61
6530 Apheresis Allogeneic Myelodysplastic Syndrome Refractory Anemia With Blast Proliferation Ii Hematology 2018 Standard Therapy Germany 57
6531 Apheresis Allogeneic Myelodysplastic Syndrome; Acute Lymphoblastic Leukemia Hematology 2018 Standard Therapy Germany 65
6532 Apheresis Allogeneic Myelodysplastic Syndrome; Acute Myelogenous Leukemia Hematology 2018 Standard Therapy Poland 74
6533 Apheresis Allogeneic Myelodysplastic Syndrome; Myeloproliferative Neoplasms Hematology 2018 Standard Therapy Germany 62
6534 Apheresis Allogeneic Myelofibrosis Hematology 2018 Standard Therapy Poland 49
6535 Apheresis Allogeneic Myelofibrosis Hematology 2018 Standard Therapy Poland 60
6536 Apheresis Allogeneic Myelofibrosis Hematology 2018 Standard Therapy Poland 56
6537 Apheresis Allogeneic Myelofibrosis Hematology 2018 Standard Therapy Poland 58
6538 Apheresis Allogeneic Myelofibrosis Hematology 2018 Standard Therapy Poland 64
6539 Apheresis Allogeneic Myelofibrosis Hematology 2018 Standard Therapy Poland 68
6540 Apheresis Allogeneic Myelofibrosis Hematology 2018 Standard Therapy Poland 72
6541 Apheresis Allogeneic Myelofibrosis Hematology 2018 Standard Therapy Poland 53
6542 Apheresis Allogeneic Myeloma Multiplex Hematology 2018 Standard Therapy Poland 56
6543 Apheresis Allogeneic Myeloma Multiplex Hematology 2018 Standard Therapy Poland 57
6544 Apheresis Allogeneic Myeloma Multiplex Hematology 2018 Standard Therapy Poland 55
6545 Apheresis Allogeneic Myeloma Multiplex Hematology 2018 Standard Therapy Poland 52
6546 Apheresis Allogeneic Myeloproliferative Neoplasms Hematology 2018 Standard Therapy Poland 61
6547 Apheresis Allogeneic No Data Hematology 2018 Standard Therapy Poland 69
6548 Apheresis Allogeneic No Data Hematology 2018 Standard Therapy Poland 70
6549 Apheresis Allogeneic No Data Hematology 2018 Standard Therapy Poland 38
6550 Apheresis Allogeneic No Data Hematology 2018 Standard Therapy Poland 22
6551 Apheresis Allogeneic No Data Hematology 2018 Standard Therapy Poland 60
6552 Apheresis Allogeneic No Data Hematology 2018 Standard Therapy Poland 19
6553 Apheresis Allogeneic No Data Hematology 2018 Standard Therapy Poland 65
6554 Apheresis Allogeneic No Data Hematology 2018 Standard Therapy Poland 22
6555 Apheresis Allogeneic No Data Hematology 2018 Standard Therapy Poland 67
6556 Apheresis Allogeneic No Data Hematology 2018 Standard Therapy Poland 46
6557 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Poland 23
6558 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Poland 69
6559 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Poland 70
6560 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Poland 17
6561 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Poland 31
6562 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Poland 66
6563 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Poland 17
6564 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Poland 58
6565 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Poland 11
6566 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Poland 64
6567 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Poland 30
6568 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Poland 54
6569 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Germany 72
6570 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Germany 54
6571 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Germany 58
6572 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Germany 63
6573 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Germany 48
6574 Apheresis Autologous Non-Hodgkin Lymphoma Hematology 2018 Standard Therapy Germany 62
6575 Apheresis Allogeneic Non-Hodgkin Lymphoma; Diffuse Large B-Cell Lymphoma Hematology 2018 Standard Therapy Poland 62
6576 Apheresis Autologous Non-Hodgkin-Lymphoma-Relapse Hematology 2018 Standard Therapy Germany 51
6577 Apheresis Allogeneic Other Malignancy Hematology 2018 Standard Therapy Poland 59
6578 Apheresis Allogeneic Other Myelodysplastic Syndromes Hematology 2018 Standard Therapy Poland 67
6579 Apheresis Allogeneic Other Myelofibrosis Hematology 2018 Standard Therapy Poland 57
6580 Apheresis Allogeneic Peripheral T-Cell Lymphoma Hematology 2018 Standard Therapy Poland 50
6581 Apheresis Allogeneic Plasma Cell Disorder Hematology 2018 Standard Therapy Poland 64
6582 Apheresis Allogeneic Plasma Cell Disorder Hematology 2018 Standard Therapy Poland 57
6583 Apheresis Autologous Plasma Cell Leukemia Hematology 2018 Standard Therapy Germany 52
6584 Apheresis Allogeneic Post-Essential Thrombocythemia-Myelofibrosis Hematology 2018 Standard Therapy Germany 53
6585 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2018 Standard Therapy Germany 67
6586 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2018 Standard Therapy Germany 69
6587 Apheresis Autologous Primary Central Nervous System Lymphoma Hematology 2018 Standard Therapy Germany 66
6588 Apheresis Autologous Primary Central Nervous System Lymphoma Relapse Hematology 2018 Standard Therapy Germany 63
6589 Apheresis Allogeneic Primary Immunodeficiency Hematology 2018 Standard Therapy Poland 3
6590 Apheresis Allogeneic Primary Myelofibrosis; Secondary Acute Myelogenous Leukemia Hematology 2018 Standard Therapy Poland 53
6591 Apheresis Allogeneic Prolymphocytic Leukemia Hematology 2018 Standard Therapy Poland 62
6592 Apheresis Autologous Refractory Diffuse Large B-Cell Lymphoma Hematology 2018 Standard Therapy Germany 36
6593 Apheresis Allogeneic Refractory Diffuse Large B-Cell Lymphoma Hematology 2018 Standard Therapy Germany 50
6594 Apheresis Allogeneic Secondary Acute Myeloid Leukemia Hematology 2018 Standard Therapy Poland 58
6595 Apheresis Allogeneic Secondary Acute Myeloid Leukemia Hematology 2018 Standard Therapy Germany 68
6596 Apheresis Allogeneic Secondary Acute Myeloid Leukemia At Primary Myelofibrosis Hematology 2018 Standard Therapy Germany 56
6597 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2018 Standard Therapy Poland 18
6598 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2018 Standard Therapy Poland 74
6599 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2018 Standard Therapy Poland 24
6600 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2018 Standard Therapy Poland 70